Global Health: What’s Ahead for 2022: Digital Health/Artificial Intelligence (AI)
Digital innovation continues to rapidly transform healthcare while, at the same time, raising several policy challenges, including privac...
Digital innovation continues to rapidly transform healthcare while, at the same time, raising several policy challenges, including privac...
Rare diseases are considered rare because they affect relatively tiny numbers of people: up to 200,000 in the U.S., for example, and less...
No look ahead at women’s health issues in 2022 would be complete without a discussion of thecontinuing impact of the COVID-19 pandemic. C...
Historically, the World Health Organization (WHO) has led extraordinary efforts to eliminate, and even eradicate, highly communicable dis...
Antimicrobial resistance (AMR), which is making a growing range of antibiotics ineffective, is anincreasingly critical problem. Driven la...
It’s fair to say that the current state of health financing is mixed. On the one hand, outside of pandemic-related funding, public financ...
Nothing in recent years has focused the world’s attention on the development, use, and efficacy of vaccines more than COVID-19. Through e...
Comparing the road ahead for mandatory corporate ESG disclosures in the two markets.
Moving toward uniform environmental reporting standards to catalyze corporate performance.
Five things we will be looking for from G20 leaders, health and finance officials.